Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

Rheumatology (Oxford, England)

Volumn 53, Issue 12, 2014, Pages 2223-2231

  Calvo Río, Vanesa ^a   Blanco, Ricardo ^a   Beltrán, Emma ^a   Sánchez Bursón, Juán ^a   Mesquida, Marina ^a   Adán, Alfredo ^b   Hernandez, María Victoria ^a   Hernandez Garfella, Marisa ^a   Valls Pascual, Elia ^a   Martínez Costa, Lucía ^a   Sellas Fernández, Agustí ^a   Cordero Coma, Miguel ^a   Díaz Llopis, Manuel ^a   Gallego, Roberto ^a   Salom, David ^a   García Serrano, José L ^a   Ortego, Norberto ^a   Herreras, José M ^a   Fonollosa, Alejandro ^a   García Aparicio, Angel M ^a   Maíz, Olga ^a   Blanco, Ana ^a   Torre, Ignacio ^a   Fernández Espartero, Cruz ^a   Jovani, Vega ^a   Peiteado Lopez, Diana ^a   Pato, Esperanza ^a   Cruz, Juan ^a   Fernández Cid, Carlos ^a   Aurrecoechea, Elena ^a   García, Miriam ^a   Caracuel, Miguel A ^a   Montilla, Carlos ^a   Atanes, Antonio ^a   Hernandez, Félix Francisco ^a   Insua, Santos ^a   González Suárez, Senén ^a   Sánchez Andrade, Amalia ^a   Gamero, Fernando ^a   Linares, Luis ^a   Romero Bueno, Fredeswinda ^a   García, A Javier ^a   Almodovar, Raquel ^a   Minguez, Enrique ^a   Carrasco Cubero, Carmen ^a   Olive, Alejandro ^a   Vázquez, Julio ^a   Ruiz Moreno, Oscar ^a   Jiménez Zorzo, Fernando ^a   Manero, Javier ^a   Muñoz Fernández, Santiago ^a   Rueda Gotor, Javier ^a   González Gay, Miguel A ^a   more..

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

anti TNF therapy; Beh et s disease; uveitis

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ANTAGONISTS AND INHIBITORS; BEHCET SYNDROME; CHILD; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; TREATMENT OUTCOME; UVEITIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BEHCET SYNDROME; BIOLOGICAL PRODUCTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISONE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS; YOUNG ADULT;

EID: 84925222981     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu266     Document Type: Article

References (0)